| Devatis AG - Lenalidomid Devatis 2.5 mg, Hartkapseln | | 68518 | | 01 | | Lenalidomid Devatis 2.5 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 12.01.2022 | | |
| | Composition | | lenalidomidum 2.5 mg, lactosum 20.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.204 mg, magnesii stearas, Kapselhülle: gelatina, E 132, titanii dioxidum, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Lenalidomidum | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lenalidomidum | 2.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammoniae Solutio | 30 | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactosum | 20 mg | | | Magnesii Stearas | | | | Per Centum | | | | Pro Capsula | | | | Propylenglycol | | | | Titanium Dioxide | | |
| |
| |
|
